Daylight photodynamic therapy for prevention of new actinic keratosis and keratinocyte carcinomas in organ transplants. A cryotherapy‐controlled randomized clinical trial

• Published in: Journal of the European Academy of Dermatology and Venereology Vol. 34; no. 7; pp. 1464 - 1470
• Main Authors: Bernad, I., Aguado, L., Núñez‐Córdoba, J.M., Redondo, P.
• Format: Journal Article
• Language: English
• Published: England 01.07.2020
• Subjects: Aged; Aminolevulinic Acid - therapeutic use; Carcinoma; Cryotherapy; Humans; Keratinocytes; Keratosis, Actinic - drug therapy; Keratosis, Actinic - prevention & control; Male; Middle Aged; Organ Transplantation; Photochemotherapy; Photosensitizing Agents - therapeutic use; Treatment Outcome

Background Organ transplant recipients (OTR) have a higher risk of actinic keratosis (AK) and keratinocyte carcinomas (KC). There are no clinical trials assessing the effectiveness of daylight photodynamic therapy (DPDT) to prevent new AK and KC in OTR. Objectives To determine whether repeated treat...